PT Mitra Keluarga Karyasehat Tbk (IDX:MIKA)

CTI BioPharma Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,241,324	1,067,636	842,757	696,054	1,282,728	705,013
Short-Term Investments	579,482	1,394,395	1,091,590	1,258,479	1,534,119	1,604,339
Cash & Short-Term Investments	2,820,806	2,462,031	1,934,347	1,954,533	2,816,847	2,309,352
Cash Growth	19.52%	27.28%	-1.03%	-30.61%	21.98%	23.79%
Accounts Receivable	860,085	723,195	690,123	429,620	259,068	645,689
Other Receivables	57,050	49,750	34,286	37,312	41,985	63,303
Receivables	917,135	772,945	724,408	466,932	301,053	708,992
Inventory	59,218	62,672	81,720	62,519	67,044	55,031
Prepaid Expenses	61,244	19,137	13,165	8,015	6,122	22,210
Other Current Assets	1,843	3,744	8,585	2,376	6,447	8,018
Total Current Assets	3,860,246	3,320,529	2,762,225	2,494,376	3,197,514	3,103,603
Property, Plant & Equipment	4,457,816	4,241,608	3,817,004	3,429,721	2,696,472	2,534,240
Long-Term Investments	30,530	30,000	35,000	133,900	-	-
Goodwill	203,661	203,661	182,316	182,316	182,316	182,316
Other Intangible Assets	225,648	234,801	248,836	263,858	253,595	233,603
Long-Term Deferred Tax Assets	44,197	39,861	32,693	26,057	39,300	63,444
Other Long-Term Assets	166,911	176,730	262,768	387,864	491,774	255,073
Total Assets	8,989,009	8,247,189	7,340,843	6,918,091	6,860,971	6,372,279
Accounts Payable	233,846	215,951	196,062	172,621	205,941	201,343
Accrued Expenses	246,430	236,534	197,769	168,000	174,771	141,968
Current Portion of Leases	1,147	1,147	1,138	-	-	-
Current Income Taxes Payable	113,277	104,751	45,740	156,159	236,676	133,854
Current Unearned Revenue	30,583	28,570	16,275	14,751	24,327	29,649
Other Current Liabilities	725,848	113,477	99,112	141,081	120,747	61,618
Total Current Liabilities	1,351,131	700,430	556,096	652,612	762,461	568,432
Long-Term Leases	462.54	462.54	1,916	-	-	-
Long-Term Deferred Tax Liabilities	2,236	4,220	1,048	1,158	171.64	-
Total Liabilities	1,575,588	916,744	741,059	786,206	935,827	855,187
Common Stock	139,075	139,075	142,463	142,463	142,463	142,463
Additional Paid-In Capital	606,031	606,031	1,362,715	1,362,715	1,362,715	1,362,715
Retained Earnings	5,794,320	5,752,074	5,077,733	4,675,650	4,155,714	3,404,792
Treasury Stock	-	-	-760,072	-760,072	-406,372	-9,277
Comprehensive Income & Other	1,012	117.38	10.07	3,006	18,035	19,209
Total Common Equity	6,540,438	6,497,298	5,822,849	5,423,762	5,272,555	4,919,903
Minority Interest	872,983	833,148	776,934	708,122	652,588	597,189
Shareholders' Equity	7,413,421	7,330,445	6,599,783	6,131,884	5,925,144	5,517,092
Total Liabilities & Equity	8,989,009	8,247,189	7,340,843	6,918,091	6,860,971	6,372,279
Total Debt	1,609	1,609	3,054	-	-	-
Net Cash (Debt)	2,819,196	2,460,422	1,931,293	1,954,533	2,816,847	2,309,352
Net Cash Growth	19.61%	27.40%	-1.19%	-30.61%	21.98%	24.12%
Net Cash Per Share	202.71	176.91	137.20	138.85	198.21	162.15
Filing Date Shares Outstanding	13,907	13,907	13,907	13,907	14,068	14,241
Total Common Shares Outstanding	13,907	13,907	13,907	13,907	14,068	14,241
Working Capital	2,509,115	2,620,099	2,206,129	1,841,764	2,435,053	2,535,171
Book Value Per Share	470.28	467.18	418.68	389.99	374.79	345.48
Tangible Book Value	6,111,129	6,058,836	5,391,697	4,977,588	4,836,644	4,503,983
Tangible Book Value Per Share	439.41	435.65	387.68	357.91	343.80	316.27
Land	1,817,674	1,800,438	1,625,384	1,483,613	1,175,352	1,130,990
Buildings	2,322,171	2,252,497	1,949,098	1,667,761	1,457,786	1,467,330
Machinery	2,512,103	2,347,224	2,104,301	1,438,797	1,168,058	1,048,278
Construction In Progress	267,771	170,834	192,394	206,490	116,346	5,423

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.